Find your next paid study

~$150 – $4,500

Actual pay is set by the research site.

David AviganNCT06799026

Phase 1

Phase I Study of BCMA-TGF-BETA Insensitive Armored CAR T Cells in Patients With Relapsed and/or Refractory Multiple Myeloma

This is a phase I, interventional, single-arm, open-label, dose-finding treatment study designed to evaluate the safety and efficacy of interleukin-7(IL-7) / i…

Multiple Myeloma

Medical College of WisconsinNCT05976555

~$150 – $3,000

Actual pay is set by the research site.

Phase 3

An Open-Label Study of Donidalorsen in Pediatric Patients Age 2 to Less Than 12 Years Old With Hereditary Angioedema

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of donidalorsen in pediatric participants with hereditary angioedema (HA…

Hereditary Angioedema (HAE)

Ionis Pharmaceuticals, Inc.NCT07298447

~$50 – $2,100

Actual pay is set by the research site.

Hearing Loss, Age-RelatedSpeech IntelligibilityPsychosocial Functioning

Speech-in-noise, Psychosocial, and Heart Rate Variability Outcomes of Group Singing or Audiobook Club Interventions for Older Adults With Unaddressed Hearing Loss: a SingWell Project Multisite, Randomized Controlled Trial.

Unaddressed age-related hearing loss is highly prevalent among older adults, typified by negative consequences for speech-in-noise perception and psychosocial …

Toronto Metropolitan UniversityNCT06580847

Actual pay is set by the research site.

Phase 2

Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus

Multi-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solu…

Keratoconus

Glaukos CorporationNCT07400952

~$75 – $2,800

Actual pay is set by the research site.

Open-label Study Evaluating the Safety and Efficacy of AGE Serum in Non-menopausal Patients on Glucagon-like Peptide-1 Agonists

The primary objective is to evaluate the safety and efficacy of a topical serum (AGE serum) in improving visible signs of aging (e.g., fine lines, wrinkles, sa…

Laxity; Skin

Goldman, Butterwick, Fitzpatrick and GroffNCT07216352

~$10 – $1,125

Actual pay is set by the research site.

The Development of PATH, a Program to Support NICU Parent Mental Health Through the Transition From Hospital to Home

The objective of this study is to develop and pilot test a telehealth-based mental health screening and engagement program that supports parents as their infan…

Perinatal Mental Health

University of Colorado, DenverNCT06467916

Actual pay is set by the research site.

Molar Incisor HypomineralizationAnesthesia, Local

Effect of Silver Diamine Fluoride on Local Anesthesia Efficacy in Molar Incisor Hypomineralization-affected Molars in Children: A Randomized Clinical Trial

The purpose of this randomized, controlled clinical study is to evaluate if application of 38% SDF increases the efficacy of local anesthesia during operative …

University of MichiganNCT05964387

Actual pay is set by the research site.

Effects of a Structured, Modified Mediterranean Dietary Intervention After Liver Transplantation

The purpose of this study is to study the effects of a structured Mediterranean dietary program on prevention of weight gain, promotion of heart health and pre…

Liver Transplantation

Left-sided Colorectal Cancer

Actual pay is set by the research site.

Mayo ClinicNCT04672863

Phase 3

A Randomized, Open-label, Phase 3 Trial of Petosemtamab in Combination With mFOLFOX6 or FOLFIRI Versus Cetuximab in Combination With mFOLFOX6 or FOLFIRI as First-line Treatment for Participants With RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer

The purpose of this trial is to evaluate how well petosemtamab in combination with chemotherapy works against colorectal cancer located on the left side of the…

Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian CancerFallopian Tube Cancer+4 more

~$50 – $2,250

Actual pay is set by the research site.

GenmabNCT07702032

Phase 3

A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-doublet Chemotherapy and Bevacizumab Compared With Physician's Choice of Chemotherapy and Bevacizumab in Women With Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemothera…

Genelux CorporationNCT05281471

~$50 – $2,100

Actual pay is set by the research site.

Physical InactivityOverweight and Obesity

Designing With Dissemination in Mind: Development and Evaluation of a Theory-based Physical Activity Intervention Using the Multiphase Optimization Strategy: Aim 2

This study plans to learn more about the feasibility and acceptability of integrating the Move physical activity support program within an existing lifestyle i…